Serum alanine transaminase level is a good predictor of response to interferon alfa therapy for chronic hepatitis B in human immunodeficiency virus-infected patients.

Di Martino V, Thevenot T, Boyer N, Degos F, Marcellin P.

Hepatology. 2000 Apr;31(4):1030-1. doi: 10.1053/jhep.2000.16184.

PMID: 10777355

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.